Cisplatin with pemetrexed and atezolizumab followed by surgical resection and maintenance therapy with atezolizumab met safety criteria.
Dr. Anne Tsao of MD Anderson Cancer Center in Houston and her clinical site co-researchers randomized 24 patients with epithelioid or biphasic histology whose disease wasresectable by pleurectomy/decortication (P/D) or extrapleural pneumonectomy (EPP), who underwent surgical staging with mediastinoscopy or endobronchial ultrasound and laparoscopy, and who did not receive prior chemo or immunotherapy....
↧